Skip to content

Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan

Feasibility Study of Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02202694
Enrollment
36
Registered
2014-07-29
Start date
2012-03-31
Completion date
2014-03-31
Last updated
2017-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis

Keywords

CBT, Psychosis, cultural adaptation, Pakistan

Brief summary

Aim: To assess the feasibility of application of culturally-adapted CBT (CaCBTp) for use in Pakistan. Design: Randomized Control Trial Setting: Psychiatry Departments of General Hospitals in Karachi. Participants: A total of 36 patients with a diagnosis of psychotic disorder will be randomized to a psychological intervention or treatment as usual arm. Intervention: Culturally Adapted Cognitive Behavioral Therapy (CBT) Outcome measure: Positive and Negative syndrome scale (PANSS) Psychotic symptoms Rating Scales (PSYRATS)

Detailed description

The purpose of the study is to test the feasibility of culturally adaptive CBT for Psychosis in Pakistan Primary : -To assess the feasibility of application of culturally-adapted CBT (CaCBTp) for use in Pakistan. Secondary: * To assess fidelity of culturally-adapted CBT for psychosis. * To further modify CaCBTp in accordance with findings of feasibility study The Participants will be recruited from psychiatric department of different hospitals.They will be randomly divided into two groups; intervention group and treatment-as-usual group. A total of thirtysix participants will be recruited in the feasibility study and divided equally into two arms. This will ensure that, even after loss to follow-up, the investigators will have at least 12 subjects per group for analysis (FDA guidance http://www.fda.gov/cder/guidance/5356fnl.pdf. Randomization will be carried out by the on offsite statistician . This will provide a reliable geographically remote service. For intervention group twelve sessions of CaCBTp will be delivered by trained research clinician for a period of three months. Participants in the treatment as usual (TAU) group will be given details of intervention at the end of the study and interested Participants will be offered CaCBTp.

Interventions

BEHAVIORALCulturally Adapted Cognitive behavior therapy

This 12 session Multimodal Psychosocial Intervention will include a supportive component, an educational component, psychosocial component

Sponsors

University of Manchester
CollaboratorOTHER
Dow University of Health Sciences
CollaboratorOTHER
Abbasi Shaheed Hospital
CollaboratorOTHER
Pakistan Institute of Living and Learning
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of Psychosis established by clinician using ICD10 criteria. 2. Individuals aged between 18-65. 3. Should not have learning disability. 4. Resident of Karachi. 5. Participant is able to give informed written consent

Exclusion criteria

1. Severe illness which may affect capacity or markedly affect their ability to participate in interview, e.g. very thought disordered or distressed by symptoms. 2. Severe drug or alcohol problem (i.e., those who fulfill the criteria for dependence according to ICD10 RDC).

Design outcomes

Primary

MeasureTime frameDescription
Positive and Negative syndrome scale (PANSS)up to 6 monthsThe PANSS is a structured clinical interview consisting of 30 items designed to assess severity of symptoms over the past week on a 7-point scale.

Secondary

MeasureTime frameDescription
Psychotic Symptom Rating Scales (PSYRATS)Baseline ,3 months & 6 monthsThe PSYRATS consists of 17 items that focus on auditory hallucinations and delusions experienced over the past week.
Insight rating scaleBaseline ,3 months & 6 monthsAssesses Improvement in insight
Calgary Depression Scale for SchizophreniaBaseline ,3 months & 6 monthsThis is a nine-item scale developed by Addington et al. to assess depression in schizophrenia.
Short Explanatory Model InterviewBaseline ,3 months & 6 monthsused to elicit beliefs of mental illness

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026